Catherine Boule

Catherine’s career began at Institut Curie as a molecular biology researcher. She then joined Ile-de-France Innovation where she assisted several BioTech and MedTech companies in their development.

Joining Karista in 2003, Catherine is the Managing Partner in charge of the Healthcare practice. She is involved in the overall management of the firm, fundraising activities and investors relations. Catherine is investing in Healthcare and Digital Health ventures. She represents Karista at the board of several portfolio companies such as Acticor Biotech, Eyevensys and Incepto. She was also part of the board of Echosens (acquired by Furui Group), Erytech Pharma (listed on Nasdaq: ERYP), Nanobiotix (listed on Euronext: NANO) and many other successful companies.

Catherine holds a MSc in Molecular Biology from University Pierre and Marie Curie and graduated in Innovation Management from AgroParis Tech.